We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+2.95%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
+$950M
(+7.4%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
5.27%
Top 10 Holdings %
Top 10 Hldgs %
11.77%
Holding
2,830
New
300
Increased
700
Reduced
765
Closed
275
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corning
GLW
|
+$45.6M |
| 2 |
Accenture
ACN
|
+$41.1M |
| 3 |
OA
Orbital ATK, Inc.
OA
|
+$33.7M |
| 4 |
Hormel Foods
HRL
|
+$32.9M |
| 5 |
PACCAR
PCAR
|
+$32.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$61.7M |
| 2 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$23.5M |
| 3 |
ORB
ORBITAL SCIENCES CORP
ORB
|
+$21.2M |
| 4 |
TAL
TAL INTERNATIONAL GROUP, INC.
TAL
|
+$21.1M |
| 5 |
Hope Bancorp
HOPE
|
+$19.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.82% |
| 2 | Healthcare | 14.78% |
| 3 | Industrials | 11.92% |
| 4 | Financials | 9.77% |
| 5 | Consumer Discretionary | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NextEra Energy
NEE
$187B
| $43.2M | 0.32% |
1,660,828
-21,964
| -1% | -$579K |
|
77
Paychex
PAYX
$40.4B
| $43.2M | 0.32% |
870,694
+198,426
| +30% | +$9.64M |
|
78
Yum! Brands
YUM
$41B
| $43.1M | 0.31% |
761,685
-2,183
| -0.3% | -$119K |
|
79
Illinois Tool Works
ITW
$81.4B
| $42.4M | 0.31% |
436,927
-20,262
| -4% | -$1.95M |
|
80
NetApp
NTAP
$32.9B
| $41.9M | 0.31% |
1,182,124
+142,584
| +14% | +$5.45M |
|
81
Acadia Healthcare
ACHC
$3.17B
| $41.2M | 0.3% |
575,224
-27,587
| -5% | -$1.77M |
|
82
Steris
STE
$20.9B
| $41.1M | 0.3% |
584,297
+5,173
| +0.9% | +$341K |
|
83
Coca-Cola
KO
$354B
| $40.3M | 0.29% |
993,073
-12,004
| -1% | -$502K |
|
84
Visa
V
$677B
| $39.8M | 0.29% |
608,910
+322,530
| +113% | +$21.3M |
|
85
Franklin Resources
BEN
$16.9B
| $39.8M | 0.29% |
774,581
-92,262
| -11% | -$4.9M |
|
86
Chubb
CB
$140B
| $39.5M | 0.29% |
354,026
-2,862
| -0.8% | -$322K |
|
|
AGN
87
DELISTED
Allergan plc
AGN
| $37.9M | 0.28% |
127,512
+76,043
| +148% | +$21.7M |
|
|
AMSG
88
DELISTED
Amsurg Corp
AMSG
| $37.6M | 0.27% |
610,594
+4,977
| +0.8% | +$287K |
|
|
RTN
89
DELISTED
Raytheon Company
RTN
| $37.5M | 0.27% |
343,315
+4,472
| +1% | +$481K |
|
90
Nike
NKE
$61.9B
| $37.5M | 0.27% |
747,282
+80,012
| +12% | +$3.83M |
|
91
ConocoPhillips
COP
$147B
| $37.3M | 0.27% |
599,773
-14,847
| -2% | -$960K |
|
92
Dollar Tree
DLTR
$23.1B
| $36.8M | 0.27% |
453,421
-30,807
| -6% | -$2.34M |
|
93
Brunswick
BC
$5.19B
| $36.7M | 0.27% |
713,568
+8,392
| +1% | +$445K |
|
94
Stryker
SYK
$127B
| $36.3M | 0.26% |
393,686
-92
| -0% | -$8.56K |
|
|
95
Hormel Foods
HRL
$13.9B
| $35.9M | 0.26% |
1,264,588
+1,201,074
| +1,891% | +$32.9M |
|
96
TJX Companies
TJX
$170B
| $35.1M | 0.26% |
1,002,980
+96,340
| +11% | +$3.28M |
|
97
Ball Corp
BALL
$17B
| $34.8M | 0.25% |
985,516
+109,286
| +12% | +$3.78M |
|
98
Western Alliance Bancorporation
WAL
$9.07B
| $34.7M | 0.25% |
1,172,241
-165,168
| -12% | -$4.6M |
|
|
CB
99
DELISTED
CHUBB CORPORATION
CB
| $34.7M | 0.25% |
343,108
+4,167
| +1% | +$422K |
|
|
K
100
DELISTED
Kellanova
K
| $34.7M | 0.25% |
559,776
-17,474
| -3% | -$1.07M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2015 Portfolio in Review
As of Q1 2015, Glenmede Trust held 2,830 positions worth $13.7B, up 7.4% from $12.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Glenmede Trust deployed $723M of net new capital in Q1 2015, opening 300 new positions and adding to 700 existing holdings. Its largest new stake was Qorvo: 411,283 shares worth $32.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was NOV, an estimated $18.7M trimmed.
- Glenmede Trust's largest Q1 2015 buy was Qorvo: 411,283 shares worth $32.8M.
- Glenmede Trust added most to Corning in Q1 2015, an estimated $45.6M increase.
- Glenmede Trust's biggest Q1 2015 reduction was NOV, cutting an estimated $18.7M.
- Glenmede Trust fully exited Allergan Inc in Q1 2015, selling an estimated $61.7M.
- Glenmede Trust's ten largest holdings make up 12% of its $13.7B portfolio in Q1 2015.
- Glenmede Trust opened 300 new positions and closed 275 in Q1 2015.
- Glenmede Trust's portfolio value rose 7.4% quarter-over-quarter to $13.7B.
Based on Glenmede Trust's 13F filing for Q1 2015, filed 29 Apr 2015.